MétaCan
Menu
← Back to cohort
Record W2085823138 · doi:10.1016/j.jalz.2011.05.1433

O3‐07‐02: Bradykinin B1 receptor blockade in the treatment of Alzheimer's disease: improvement of cognitive and cerebrovascular functions and reduction of amyloidosis

2011· article· en· W2085823138 on OpenAlexaff
Baptiste Lacoste, Xin‐Kang Tong, Karim Lahjouji, Réjean Couture, Édith Hamel

Bibliographic record

VenueAlzheimer s & Dementia · 2011
Typearticle
Languageen
FieldMedicine
TopicCoagulation, Bradykinin, Polyphosphates, and Angioedema
Canadian institutionsUniversité de MontréalMcGill UniversityMontreal Neurological Institute and Hospital
Fundersnot available
KeywordsNeuroinflammationPathologyEndocrinologyMedicineNeuroscienceInternal medicinePsychologyInflammation

Abstract

fetched live from OpenAlex

Alzheimer's disease (AD) is characterized not only by a cerebrovascular pathology, amyloidosis and cognitive deficits, but also by neuroinflammation that involves the kallikrein-kinin system. Strong evidence suggests that Bradykinin (BK) and its inducible receptor B1 (B1r) may be involved in AD. Previous experiments showed that the memory deficits triggered by intracerebral injection of beta-amyloid (Ab) could be reduced by blockade of B1r. We propose that B1r are induced in the brain of AD patients and that they contribute to the development of the disease. To test our hypothesis, we used adult transgenic mice (APPSwe, Ind; J20 line) that display several salient features of AD. We studied by immunocytochemistry the distribution of B1r in brain and its association with Ab deposits and activated glia. We then attempted to reverse the cognitive and vascular deficits with the brain-penetrant B1r antagonist SSR240612 (10 mg/kg/day, 5 and 10 weeks). Learning and memory were tested in the Morris water maze. Cerebral blood flow (CBF) response evoked by whisker stimulation was monitored by laser Doppler flowmetry. Vasomotor responses were evaluated on isolated pressurized segments of middle cerebral artery using online videomicroscopy. Amyloid plaques burden and tissue levels of Ab were measured using Thioflavin-S staining, anti-Ab immunolabelling and ELISA. B1r appeared increased in APP mice, particularly in the hippocampus, where double immunostaining showed its expression by activated astrocytes (GFAP), but not microglia (CD11b), surrounding Ab deposits. Learning and memory were significantly improved after 5 and 10 weeks of SSR240612 treatment. These treatments also ameliorated evoked CBF responses. Both treatments completely rescued dilations to acetylcholine. In treated wild-type (WT) mice, however, contractions induced by endothelin-1 and NO synthesis inhibition were significantly reduced compared to untreated WT. BK elicited a biphasic response (contraction followed by relaxation) in all groups, with a tendency to constrict and dilate more in APP and treated WT mice, respectively. Finally, soluble Ab1-42 levels and Ab plaque load were significantly reduced in the brain of APP mice after both treatments. Together, these data support a role of the kallikrein-kinin system in the pathogenesis of AD, and suggest that it may represent a new therapeutic target.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.258
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicCoagulation, Bradykinin, Polyphosphates, and Angioedema→French-language works237,207→